Bullish Options Positioning Continues in Nektar Therapeutics (NKTR) -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Call Buying Activity in Nektar Therapeutics (NKTR) Highlights Upside Bias -Susquehanna
November 14, 2017 3:01 PM ESTSusquehanna options strategist Alison Edwards notes bullish options activity in Nektar Therapeutics (NASDAQ: NKTR), as an opening investor bought 2500 May 45 Calls for $4.30.
... More